sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$7.93
1 Dec 2009
+0.00%
$7.93
--
4,855,750
$8.01
$7.92
$9.99
$4.96
0.57
652,787
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| MacDonald, James |
Non-Executive Chairman of the Board, Independent Director |
-- |
| DeFalco, Stephen |
President, Chief Executive Officer, Director |
3,547,910 |
| Prince, Douglas |
Chief Financial Officer, Executive Vice President - Finance |
1,109,460 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$952.69 |
| Shares Outstanding (Mil.) |
120.14 |
| Float (Mil.) |
118.90 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend ($ CAD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
1.75 |
| Current Ratio |
2.47 |
| LT Debt/Equity |
22.94 |
| Total Debt/Equity |
26.31 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
0.96 |
| Price/Book(TTM) |
0.86 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-5.40 |
| Sales(TTM) |
$8.26 |
| Book Value(MRQ) |
$9.27 |
| Cash Flow(TTM) |
$-4.68 |
| Cash(MRQ) |
$2.59 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-43.70 |
| Return on Assets(TTM) |
-28.20 |
| Return on Investment(TTM) |
-33.74 |
| |
|
| Margins |
| Gross Margin(TTM) % |
37.29 |
| Operating Margin(TTM) % |
-77.00 |
| Profit Margin(TTM) % |
-65.76 |
|
| |
|